alpha-4/beta-7 antagonists (Millennium)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-4/beta-7 antagonists (Millennium)
Drug Alias Nameautoimmune therapeutics (Genzyme/LeukoSite)beta-7 integrin receptor antagonists (LeukoSite)small molecule IBS program (Millennium)inflammatory therapeutics (LeukoSite)A4B7 program (Millennium) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 inhibitorsMucosal addressin cell adhesion molecule-1 inhibitors
TargetsIntegrin alpha-4/beta-7Mucosal addressin cell adhesion molecule-1
Therapy Area/IndicationsInflammationAutoimmune DiseasesInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeukosite
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeukositeMillennium Pharmaceuticals IncGenzyme Corp
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A